Physician profile
Alexander E Fraley
NPI 1841385184
$11,499.50
in general payments reported to CMS, 2019-2025
20 companies · $5,488 in 2025
The $5,488 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,349 · 2020: $281 · 2021: $376 · 2022: $15.76 · 2023: $440 · 2024: $548 · 2025: $5,488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,000 · Food and Beverage: $1,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,000.00 |
| Food and Beverage | $1,476.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,146.47 | 2019-2025 | General - Structural Heart, General - Ct_ic, Bulkamid |
| Abbott Laboratories | $3,494.77 | 2019-2021 | |
| Livanova USA, INC. | $973.43 | 2019-2021 | |
| Inari Medical, INC. | $487.28 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $216.46 | 2020 | |
| Abiomed | $188.50 | 2023-2025 | Impella |
| Bard Peripheral Vascular, INC. | $185.67 | 2021-2024 | Rotarexs 6 F X 135 Cm |
| Teleflex LLC | $164.53 | 2023 | Guideliner |
| Recor Medical INC | $143.29 | 2025 | Paradise Ultrasound Renal Denervation System |
| Edwards Lifesciences Corporation | $98.76 | 2021 | |
| Novartis Pharmaceuticals Corporation | $64.20 | 2019 | |
| Becton, Dickinson and Company | $63.78 | 2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Angiodynamics, INC. | $58.58 | 2020-2025 | Venacure 1470 Pro |
| Veryan Medical Incorporated | $54.92 | 2021 | |
| Philips North America LLC | $47.74 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $39.07 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ancora Heart, INC. | $26.55 | 2024 | Accucinch |
| Regeneron Healthcare Solutions, INC. | $16.02 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.76 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Fraley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.